Skip to main content
JHMD logo
JHMD
(NYSEARCA)
John Hancock Multifactor Developed International ETF
$42.67-- (--)
Loading... - Market loading

JHMD ETF: John Hancock Multifactor Developed International ETF - Price, Holdings & Analysis

John Hancock Multifactor Developed International ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$41.99 - $42.99
52-Week High$46.03
52-Week Low$30.98
Open$42.04
Volume138.40K
Average Volume (3M)138.40K
Assets (AUM)1.18B
Expense Ratio0.39%
Total Holdings593
Inception DateDec 14, 2016
1 Day Change1.65%
1 Month Change-4.12%
6 Month Change7.07%
YTD Change2.79%
1 Year Change22.85%
52-Week Change22.99%
5 Year Change31.12%
50-Day MA$43.60
200-Day MA$40.87
RSI53.35
Stochastic %K90.86
Stochastic %D53.25
Annual Dividend$1.33
Dividend Yield3.08%
Last Dividend Ex-DateJun 30, 2026
Dividend Growth YoY16.42%
Years Dividend Growth3

Frequently Asked Questions About John Hancock Multifactor Developed International ETF

What is the current price of JHMD?

The latest JHMD price is $42.67. The 52-week range is $30.98–$46.03. JHMD has returned 23.0% over the past 52 weeks.

What is the expense ratio for JHMD?

JHMD's annual expense ratio is 0.39%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does JHMD pay dividends?

Yes, JHMD pays a 3.08% dividend yield. The last ex-dividend date was 2026-06-30. View full dividend history in the Dividends section.

What are the top holdings of JHMD?

JHMD's largest holdings are Vinci SA (1.8%), ASML Holding N.V. (1.7%), Novartis AG (1.5%) (combined weight: 5.0%). The fund holds 593 total positions. View the complete portfolio breakdown in the Holdings section.

How does JHMD compare to similar ETFs?

Compare JHMD (0.39% expense ratio, $1.18B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.